Acuta Capital Partners, LLC Biohaven Pharmaceutical Holding CO Ltd. Call Options Transaction History

Acuta Capital Partners, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2021 May 17, 2021	SELL	$64.07 - $91.75 $3.2 Million - $4.59 Million	-50,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$65.07 - $98.24 $3.25 Million - $4.91 Million	50,000 New	50,000 $4.29 Million
Q3 2019 Nov 14, 2019	SELL	$37.38 - $49.47 $1.87 Million - $2.47 Million	-50,000 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$34.52 - $53.29 $131,176 - $202,502	-3,800 Reduced 7.06%	50,000 $2.57 Million
Q2 2018 Aug 15, 2018	BUY	$23.62 - $42.29 $1.27 Million - $2.28 Million	53,800 New	53,800 $2.13 Million

792K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.18B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Acuta Capital Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Acuta Capital Partners, LLC with notifications on news.